nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2C9—Donepezil—Alzheimer's disease	0.261	0.373	CbGbCtD
Sulfadiazine—CYP3A4—Rivastigmine—Alzheimer's disease	0.19	0.271	CbGbCtD
Sulfadiazine—CYP3A4—Donepezil—Alzheimer's disease	0.152	0.217	CbGbCtD
Sulfadiazine—CYP3A4—Galantamine—Alzheimer's disease	0.0979	0.14	CbGbCtD
Sulfadiazine—Goitre—Donepezil—Alzheimer's disease	0.0109	0.0405	CcSEcCtD
Sulfadiazine—Periorbital oedema—Donepezil—Alzheimer's disease	0.0098	0.0366	CcSEcCtD
Sulfadiazine—Goitre—Rivastigmine—Alzheimer's disease	0.00964	0.036	CcSEcCtD
Sulfadiazine—Periorbital oedema—Rivastigmine—Alzheimer's disease	0.00871	0.0325	CcSEcCtD
Sulfadiazine—Skin discolouration—Donepezil—Alzheimer's disease	0.00429	0.016	CcSEcCtD
Sulfadiazine—Vascular purpura—Galantamine—Alzheimer's disease	0.00406	0.0151	CcSEcCtD
Sulfadiazine—Skin discolouration—Rivastigmine—Alzheimer's disease	0.00381	0.0142	CcSEcCtD
Sulfadiazine—Purpura—Galantamine—Alzheimer's disease	0.00377	0.0141	CcSEcCtD
Sulfadiazine—Oliguria—Rivastigmine—Alzheimer's disease	0.00374	0.0139	CcSEcCtD
Sulfadiazine—Ataxia—Galantamine—Alzheimer's disease	0.00341	0.0127	CcSEcCtD
Sulfadiazine—Sepsis—Donepezil—Alzheimer's disease	0.00336	0.0125	CcSEcCtD
Sulfadiazine—Skin exfoliation—Memantine—Alzheimer's disease	0.00336	0.0125	CcSEcCtD
Sulfadiazine—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.00329	0.0123	CcSEcCtD
Sulfadiazine—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00312	0.0116	CcSEcCtD
Sulfadiazine—Sepsis—Memantine—Alzheimer's disease	0.00305	0.0114	CcSEcCtD
Sulfadiazine—Sepsis—Rivastigmine—Alzheimer's disease	0.00299	0.0111	CcSEcCtD
Sulfadiazine—Polyuria—Memantine—Alzheimer's disease	0.00291	0.0109	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00288	0.0108	CcSEcCtD
Sulfadiazine—Vascular purpura—Memantine—Alzheimer's disease	0.00286	0.0107	CcSEcCtD
Sulfadiazine—Polyuria—Rivastigmine—Alzheimer's disease	0.00285	0.0106	CcSEcCtD
Sulfadiazine—Vascular purpura—Rivastigmine—Alzheimer's disease	0.00279	0.0104	CcSEcCtD
Sulfadiazine—Depression—Galantamine—Alzheimer's disease	0.00279	0.0104	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.00274	0.0102	CcSEcCtD
Sulfadiazine—Purpura—Memantine—Alzheimer's disease	0.00265	0.00989	CcSEcCtD
Sulfadiazine—Ataxia—Donepezil—Alzheimer's disease	0.00265	0.00987	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Memantine—Alzheimer's disease	0.00262	0.00977	CcSEcCtD
Sulfadiazine—Purpura—Rivastigmine—Alzheimer's disease	0.00259	0.00967	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00256	0.00955	CcSEcCtD
Sulfadiazine—Hepatitis—Galantamine—Alzheimer's disease	0.00251	0.00937	CcSEcCtD
Sulfadiazine—Hallucination—Galantamine—Alzheimer's disease	0.0025	0.00932	CcSEcCtD
Sulfadiazine—Ataxia—Memantine—Alzheimer's disease	0.0024	0.00896	CcSEcCtD
Sulfadiazine—Pancreatitis—Donepezil—Alzheimer's disease	0.00238	0.00889	CcSEcCtD
Sulfadiazine—Ataxia—Rivastigmine—Alzheimer's disease	0.00235	0.00877	CcSEcCtD
Sulfadiazine—Tinnitus—Galantamine—Alzheimer's disease	0.00234	0.00874	CcSEcCtD
Sulfadiazine—Pancreatitis—Memantine—Alzheimer's disease	0.00216	0.00808	CcSEcCtD
Sulfadiazine—Depression—Donepezil—Alzheimer's disease	0.00216	0.00807	CcSEcCtD
Sulfadiazine—Pancreatitis—Rivastigmine—Alzheimer's disease	0.00212	0.0079	CcSEcCtD
Sulfadiazine—Vertigo—Galantamine—Alzheimer's disease	0.00196	0.00733	CcSEcCtD
Sulfadiazine—Depression—Memantine—Alzheimer's disease	0.00196	0.00732	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00195	0.00728	CcSEcCtD
Sulfadiazine—Hepatitis—Donepezil—Alzheimer's disease	0.00195	0.00726	CcSEcCtD
Sulfadiazine—Hallucination—Donepezil—Alzheimer's disease	0.00194	0.00722	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00193	0.0072	CcSEcCtD
Sulfadiazine—Depression—Rivastigmine—Alzheimer's disease	0.00192	0.00716	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00191	0.00712	CcSEcCtD
Sulfadiazine—Convulsion—Galantamine—Alzheimer's disease	0.00189	0.00707	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00189	0.00704	CcSEcCtD
Sulfadiazine—Arthralgia—Galantamine—Alzheimer's disease	0.00186	0.00694	CcSEcCtD
Sulfadiazine—Agranulocytosis—Memantine—Alzheimer's disease	0.00184	0.00685	CcSEcCtD
Sulfadiazine—Tinnitus—Donepezil—Alzheimer's disease	0.00181	0.00677	CcSEcCtD
Sulfadiazine—Hepatitis—Memantine—Alzheimer's disease	0.00177	0.00659	CcSEcCtD
Sulfadiazine—Hallucination—Memantine—Alzheimer's disease	0.00176	0.00656	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00175	0.00652	CcSEcCtD
Sulfadiazine—Chills—Donepezil—Alzheimer's disease	0.00175	0.00652	CcSEcCtD
Sulfadiazine—Hepatitis—Rivastigmine—Alzheimer's disease	0.00173	0.00645	CcSEcCtD
Sulfadiazine—Hallucination—Rivastigmine—Alzheimer's disease	0.00172	0.00642	CcSEcCtD
Sulfadiazine—Anorexia—Galantamine—Alzheimer's disease	0.0017	0.00635	CcSEcCtD
Sulfadiazine—Erythema multiforme—Memantine—Alzheimer's disease	0.00167	0.00623	CcSEcCtD
Sulfadiazine—Tinnitus—Memantine—Alzheimer's disease	0.00165	0.00615	CcSEcCtD
Sulfadiazine—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00163	0.0061	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00163	0.00606	CcSEcCtD
Sulfadiazine—Insomnia—Galantamine—Alzheimer's disease	0.00161	0.00602	CcSEcCtD
Sulfadiazine—Tinnitus—Rivastigmine—Alzheimer's disease	0.00161	0.00601	CcSEcCtD
Sulfadiazine—Chills—Memantine—Alzheimer's disease	0.00159	0.00592	CcSEcCtD
Sulfadiazine—Chills—Rivastigmine—Alzheimer's disease	0.00155	0.00579	CcSEcCtD
Sulfadiazine—Decreased appetite—Galantamine—Alzheimer's disease	0.00155	0.00579	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00154	0.00575	CcSEcCtD
Sulfadiazine—Vertigo—Donepezil—Alzheimer's disease	0.00152	0.00568	CcSEcCtD
Sulfadiazine—Convulsion—Donepezil—Alzheimer's disease	0.00147	0.00548	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00146	0.00544	CcSEcCtD
Sulfadiazine—Arthralgia—Donepezil—Alzheimer's disease	0.00144	0.00538	CcSEcCtD
Sulfadiazine—Body temperature increased—Galantamine—Alzheimer's disease	0.00141	0.00526	CcSEcCtD
Sulfadiazine—Abdominal pain—Galantamine—Alzheimer's disease	0.00141	0.00526	CcSEcCtD
Sulfadiazine—Vertigo—Memantine—Alzheimer's disease	0.00138	0.00516	CcSEcCtD
Sulfadiazine—Leukopenia—Memantine—Alzheimer's disease	0.00138	0.00514	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00135	0.00505	CcSEcCtD
Sulfadiazine—Vertigo—Rivastigmine—Alzheimer's disease	0.00135	0.00504	CcSEcCtD
Sulfadiazine—Convulsion—Memantine—Alzheimer's disease	0.00133	0.00497	CcSEcCtD
Sulfadiazine—Anorexia—Donepezil—Alzheimer's disease	0.00132	0.00492	CcSEcCtD
Sulfadiazine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00131	0.0049	CcSEcCtD
Sulfadiazine—Arthralgia—Memantine—Alzheimer's disease	0.00131	0.00489	CcSEcCtD
Sulfadiazine—Convulsion—Rivastigmine—Alzheimer's disease	0.0013	0.00486	CcSEcCtD
Sulfadiazine—Arthralgia—Rivastigmine—Alzheimer's disease	0.00128	0.00478	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00126	0.0047	CcSEcCtD
Sulfadiazine—Insomnia—Donepezil—Alzheimer's disease	0.00125	0.00467	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Memantine—Alzheimer's disease	0.00123	0.00459	CcSEcCtD
Sulfadiazine—Diarrhoea—Galantamine—Alzheimer's disease	0.00122	0.00455	CcSEcCtD
Sulfadiazine—Sulfasalazine—PPARG—Alzheimer's disease	0.00121	0.196	CrCbGaD
Sulfadiazine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.0012	0.00449	CcSEcCtD
Sulfadiazine—Decreased appetite—Donepezil—Alzheimer's disease	0.0012	0.00448	CcSEcCtD
Sulfadiazine—Anorexia—Memantine—Alzheimer's disease	0.0012	0.00446	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00119	0.00445	CcSEcCtD
Sulfadiazine—Anorexia—Rivastigmine—Alzheimer's disease	0.00117	0.00437	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00114	0.00427	CcSEcCtD
Sulfadiazine—Insomnia—Memantine—Alzheimer's disease	0.00114	0.00424	CcSEcCtD
Sulfadiazine—Vomiting—Galantamine—Alzheimer's disease	0.00113	0.00423	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00113	0.00422	CcSEcCtD
Sulfadiazine—Rash—Galantamine—Alzheimer's disease	0.00112	0.0042	CcSEcCtD
Sulfadiazine—Dermatitis—Galantamine—Alzheimer's disease	0.00112	0.00419	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00112	0.00417	CcSEcCtD
Sulfadiazine—Headache—Galantamine—Alzheimer's disease	0.00112	0.00417	CcSEcCtD
Sulfadiazine—Insomnia—Rivastigmine—Alzheimer's disease	0.00111	0.00414	CcSEcCtD
Sulfadiazine—Urticaria—Donepezil—Alzheimer's disease	0.0011	0.0041	CcSEcCtD
Sulfadiazine—Abdominal pain—Donepezil—Alzheimer's disease	0.00109	0.00408	CcSEcCtD
Sulfadiazine—Body temperature increased—Donepezil—Alzheimer's disease	0.00109	0.00408	CcSEcCtD
Sulfadiazine—Decreased appetite—Memantine—Alzheimer's disease	0.00109	0.00407	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00108	0.00404	CcSEcCtD
Sulfadiazine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00107	0.00398	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00106	0.00396	CcSEcCtD
Sulfadiazine—Nausea—Galantamine—Alzheimer's disease	0.00106	0.00395	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00103	0.00383	CcSEcCtD
Sulfadiazine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00102	0.0038	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.001	0.00375	CcSEcCtD
Sulfadiazine—Urticaria—Memantine—Alzheimer's disease	0.000997	0.00372	CcSEcCtD
Sulfadiazine—Abdominal pain—Memantine—Alzheimer's disease	0.000992	0.0037	CcSEcCtD
Sulfadiazine—Body temperature increased—Memantine—Alzheimer's disease	0.000992	0.0037	CcSEcCtD
Sulfadiazine—Pruritus—Donepezil—Alzheimer's disease	0.000978	0.00365	CcSEcCtD
Sulfadiazine—Urticaria—Rivastigmine—Alzheimer's disease	0.000976	0.00364	CcSEcCtD
Sulfadiazine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000971	0.00362	CcSEcCtD
Sulfadiazine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000971	0.00362	CcSEcCtD
Sulfadiazine—Diarrhoea—Donepezil—Alzheimer's disease	0.000946	0.00353	CcSEcCtD
Sulfadiazine—Hypersensitivity—Memantine—Alzheimer's disease	0.000925	0.00345	CcSEcCtD
Sulfadiazine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000905	0.00338	CcSEcCtD
Sulfadiazine—Sulfasalazine—PTGS1—Alzheimer's disease	0.000896	0.144	CrCbGaD
Sulfadiazine—Pruritus—Memantine—Alzheimer's disease	0.000888	0.00331	CcSEcCtD
Sulfadiazine—Dapsone—MPO—Alzheimer's disease	0.000886	0.143	CrCbGaD
Sulfadiazine—Vomiting—Donepezil—Alzheimer's disease	0.000879	0.00328	CcSEcCtD
Sulfadiazine—Rash—Donepezil—Alzheimer's disease	0.000872	0.00325	CcSEcCtD
Sulfadiazine—Dermatitis—Donepezil—Alzheimer's disease	0.000871	0.00325	CcSEcCtD
Sulfadiazine—Pruritus—Rivastigmine—Alzheimer's disease	0.000869	0.00324	CcSEcCtD
Sulfadiazine—Headache—Donepezil—Alzheimer's disease	0.000866	0.00323	CcSEcCtD
Sulfadiazine—Diarrhoea—Memantine—Alzheimer's disease	0.000859	0.0032	CcSEcCtD
Sulfadiazine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00084	0.00314	CcSEcCtD
Sulfadiazine—Nausea—Donepezil—Alzheimer's disease	0.000821	0.00306	CcSEcCtD
Sulfadiazine—Vomiting—Memantine—Alzheimer's disease	0.000798	0.00298	CcSEcCtD
Sulfadiazine—Rash—Memantine—Alzheimer's disease	0.000792	0.00295	CcSEcCtD
Sulfadiazine—Dermatitis—Memantine—Alzheimer's disease	0.000791	0.00295	CcSEcCtD
Sulfadiazine—Headache—Memantine—Alzheimer's disease	0.000786	0.00293	CcSEcCtD
Sulfadiazine—Vomiting—Rivastigmine—Alzheimer's disease	0.000781	0.00291	CcSEcCtD
Sulfadiazine—Rash—Rivastigmine—Alzheimer's disease	0.000774	0.00289	CcSEcCtD
Sulfadiazine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000774	0.00289	CcSEcCtD
Sulfadiazine—Headache—Rivastigmine—Alzheimer's disease	0.000769	0.00287	CcSEcCtD
Sulfadiazine—Nausea—Memantine—Alzheimer's disease	0.000746	0.00278	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—PTGS1—Alzheimer's disease	0.000742	0.12	CrCbGaD
Sulfadiazine—Nausea—Rivastigmine—Alzheimer's disease	0.000729	0.00272	CcSEcCtD
Sulfadiazine—Sulfaphenazole—CYP2D6—Alzheimer's disease	0.000597	0.0962	CrCbGaD
Sulfadiazine—Dapsone—PTGS1—Alzheimer's disease	0.000581	0.0937	CrCbGaD
Sulfadiazine—Sulfasalazine—PTGS2—Alzheimer's disease	0.000512	0.0826	CrCbGaD
Sulfadiazine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.000463	0.0188	CbGpPWpGaD
Sulfadiazine—CYP2E1—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000461	0.0187	CbGpPWpGaD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000449	0.0182	CbGpPWpGaD
Sulfadiazine—CYP2E1—Folate-Alcohol and Cancer Pathway—CREB1—Alzheimer's disease	0.000445	0.018	CbGpPWpGaD
Sulfadiazine—CYP2E1—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000443	0.018	CbGpPWpGaD
Sulfadiazine—Sulfanilamide—CYP2D6—Alzheimer's disease	0.000443	0.0715	CrCbGaD
Sulfadiazine—CYP2C8—Xenobiotics—CYP2D6—Alzheimer's disease	0.000415	0.0168	CbGpPWpGaD
Sulfadiazine—CYP2C8—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000399	0.0161	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000388	0.0157	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000386	0.0156	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000383	0.0155	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000364	0.0147	CbGpPWpGaD
Sulfadiazine—CYP2C9—Xenobiotics—CYP2D6—Alzheimer's disease	0.000337	0.0137	CbGpPWpGaD
Sulfadiazine—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000333	0.0135	CbGpPWpGaD
Sulfadiazine—Dapsone—PTGS2—Alzheimer's disease	0.000332	0.0535	CrCbGaD
Sulfadiazine—CYP2E1—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000332	0.0134	CbGpPWpGaD
Sulfadiazine—CYP2C9—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000325	0.0131	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000316	0.0128	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000315	0.0127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000312	0.0126	CbGpPWpGaD
Sulfadiazine—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000281	0.0114	CbGpPWpGaD
Sulfadiazine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000272	0.011	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000268	0.0108	CbGpPWpGaD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000266	0.0108	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000256	0.0104	CbGpPWpGaD
Sulfadiazine—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000223	0.00901	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000217	0.0088	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000214	0.00867	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000208	0.00844	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000206	0.00833	CbGpPWpGaD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000203	0.00823	CbGpPWpGaD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000199	0.00807	CbGpPWpGaD
Sulfadiazine—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000197	0.00796	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP46A1—Alzheimer's disease	0.000193	0.00783	CbGpPWpGaD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000191	0.00775	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000191	0.00773	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000188	0.0076	CbGpPWpGaD
Sulfadiazine—CYP2E1—Vitamin A and Carotenoid Metabolism—LPL—Alzheimer's disease	0.000177	0.00716	CbGpPWpGaD
Sulfadiazine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000173	0.00702	CbGpPWpGaD
Sulfadiazine—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000173	0.00701	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000172	0.00697	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.00017	0.00688	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000169	0.00684	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP46A1—Alzheimer's disease	0.000167	0.00677	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000165	0.00669	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000165	0.00668	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000165	0.00667	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000161	0.00654	CbGpPWpGaD
Sulfadiazine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000156	0.00631	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000154	0.00623	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000153	0.00619	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000142	0.00576	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.00014	0.00567	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.00014	0.00565	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000138	0.0056	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	0.000136	0.00551	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000134	0.00543	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000126	0.00511	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000116	0.00469	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—MAOB—Alzheimer's disease	0.000115	0.00467	CbGpPWpGaD
Sulfadiazine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000114	0.00462	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000114	0.0046	CbGpPWpGaD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.00011	0.00444	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000101	0.00408	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—MAOB—Alzheimer's disease	9.98e-05	0.00404	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	9.62e-05	0.0039	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	9.24e-05	0.00374	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	9.12e-05	0.00369	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	8.97e-05	0.00363	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	8.85e-05	0.00358	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—PTGS1—Alzheimer's disease	8.75e-05	0.00354	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP2D6—Alzheimer's disease	8.58e-05	0.00347	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	8.46e-05	0.00343	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	8.12e-05	0.00329	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	7.83e-05	0.00317	CbGpPWpGaD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	7.79e-05	0.00315	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	7.64e-05	0.00309	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—PTGS1—Alzheimer's disease	7.56e-05	0.00306	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	7.49e-05	0.00303	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP2D6—Alzheimer's disease	7.41e-05	0.003	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP2D6—Alzheimer's disease	7.31e-05	0.00296	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	7.23e-05	0.00293	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	6.96e-05	0.00282	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	6.42e-05	0.0026	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	6.34e-05	0.00257	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	6.15e-05	0.00249	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	6.03e-05	0.00244	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	5.95e-05	0.00241	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	5.66e-05	0.00229	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	5.35e-05	0.00217	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	5.23e-05	0.00212	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—DHCR24—Alzheimer's disease	4.96e-05	0.00201	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—DHCR24—Alzheimer's disease	4.29e-05	0.00174	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CA4—Alzheimer's disease	4.22e-05	0.00171	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	4.06e-05	0.00164	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4e-05	0.00162	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	3.98e-05	0.00161	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GAPDHS—Alzheimer's disease	3.96e-05	0.0016	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.93e-05	0.00159	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ATP5A1—Alzheimer's disease	3.76e-05	0.00152	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CA4—Alzheimer's disease	3.64e-05	0.00148	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PLD3—Alzheimer's disease	3.58e-05	0.00145	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.56e-05	0.00144	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	3.49e-05	0.00141	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HSD17B10—Alzheimer's disease	3.44e-05	0.00139	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GAPDHS—Alzheimer's disease	3.43e-05	0.00139	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP46A1—Alzheimer's disease	3.31e-05	0.00134	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.25e-05	0.00132	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ATP5A1—Alzheimer's disease	3.25e-05	0.00132	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ND1—Alzheimer's disease	3.2e-05	0.00129	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PLD3—Alzheimer's disease	3.1e-05	0.00125	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.1e-05	0.00125	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.06e-05	0.00124	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	2.97e-05	0.0012	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CA4—Alzheimer's disease	2.97e-05	0.0012	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.9e-05	0.00118	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.9e-05	0.00117	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	2.86e-05	0.00116	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	2.79e-05	0.00113	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ND1—Alzheimer's disease	2.76e-05	0.00112	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.7e-05	0.00109	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	2.64e-05	0.00107	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PLD3—Alzheimer's disease	2.52e-05	0.00102	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.52e-05	0.00102	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.49e-05	0.00101	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.47e-05	0.001	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	2.42e-05	0.000979	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.36e-05	0.000957	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	2.33e-05	0.000942	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.3e-05	0.000931	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ND1—Alzheimer's disease	2.25e-05	0.00091	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.2e-05	0.00089	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.13e-05	0.000862	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CHAT—Alzheimer's disease	2.06e-05	0.000834	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TPI1—Alzheimer's disease	2.06e-05	0.000834	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.01e-05	0.000814	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MAOB—Alzheimer's disease	1.97e-05	0.000799	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.96e-05	0.000792	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.94e-05	0.000784	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	1.9e-05	0.000769	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.84e-05	0.000745	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—A2M—Alzheimer's disease	1.84e-05	0.000743	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.78e-05	0.000721	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.78e-05	0.000721	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.74e-05	0.000706	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.73e-05	0.000701	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.71e-05	0.000691	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.66e-05	0.000673	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.64e-05	0.000665	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.62e-05	0.000657	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.61e-05	0.000651	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ACHE—Alzheimer's disease	1.6e-05	0.000646	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.59e-05	0.000646	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.59e-05	0.000642	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	1.58e-05	0.000639	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.58e-05	0.000638	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.53e-05	0.000621	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ENO1—Alzheimer's disease	1.5e-05	0.000606	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	1.5e-05	0.000606	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.48e-05	0.0006	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	1.47e-05	0.000594	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.45e-05	0.000586	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.45e-05	0.000586	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.41e-05	0.000573	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—BCHE—Alzheimer's disease	1.39e-05	0.000563	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.39e-05	0.000562	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.38e-05	0.000559	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.36e-05	0.000552	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.34e-05	0.000541	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.32e-05	0.000535	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	1.31e-05	0.000531	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.31e-05	0.00053	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.29e-05	0.000524	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.29e-05	0.000524	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.29e-05	0.000523	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	1.27e-05	0.000515	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.27e-05	0.000513	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—BCHE—Alzheimer's disease	1.2e-05	0.000487	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.15e-05	0.000466	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	1.13e-05	0.000459	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.12e-05	0.000455	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.11e-05	0.000451	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.11e-05	0.000449	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	1.1e-05	0.000445	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	1.1e-05	0.000444	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	1.09e-05	0.000442	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.05e-05	0.000426	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.05e-05	0.000426	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.03e-05	0.000418	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LPL—Alzheimer's disease	9.98e-06	0.000404	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	9.78e-06	0.000396	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	9.55e-06	0.000387	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	9.55e-06	0.000387	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	9.48e-06	0.000384	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	9.43e-06	0.000382	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	9.23e-06	0.000374	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	9.16e-06	0.000371	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.06e-06	0.000367	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	8.99e-06	0.000364	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	8.95e-06	0.000362	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	8.82e-06	0.000357	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LPL—Alzheimer's disease	8.63e-06	0.000349	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—A2M—Alzheimer's disease	8.51e-06	0.000345	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CALM1—Alzheimer's disease	8.4e-06	0.00034	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOE—Alzheimer's disease	8.37e-06	0.000339	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CAV1—Alzheimer's disease	8.29e-06	0.000336	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	7.77e-06	0.000315	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	7.71e-06	0.000312	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	7.68e-06	0.000311	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	7.41e-06	0.0003	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	7.32e-06	0.000296	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	7.29e-06	0.000295	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CALM1—Alzheimer's disease	7.26e-06	0.000294	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOE—Alzheimer's disease	7.23e-06	0.000293	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CAV1—Alzheimer's disease	7.16e-06	0.00029	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—INS—Alzheimer's disease	7.15e-06	0.000289	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LPL—Alzheimer's disease	7.02e-06	0.000284	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	6.94e-06	0.000281	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	6.94e-06	0.000281	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	6.81e-06	0.000276	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	6.45e-06	0.000261	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	6.32e-06	0.000256	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARG—Alzheimer's disease	6.3e-06	0.000255	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	6.27e-06	0.000254	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—INS—Alzheimer's disease	6.18e-06	0.00025	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	6.09e-06	0.000247	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	5.91e-06	0.000239	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.9e-06	0.000239	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOE—Alzheimer's disease	5.89e-06	0.000238	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	5.83e-06	0.000236	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	5.73e-06	0.000232	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NOS3—Alzheimer's disease	5.42e-06	0.000219	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	5.13e-06	0.000208	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.09e-06	0.000206	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.06e-06	0.000205	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—INS—Alzheimer's disease	5.03e-06	0.000204	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	4.96e-06	0.000201	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.63e-06	0.000188	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	4.41e-06	0.000179	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.17e-06	0.000169	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	4.03e-06	0.000163	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.9e-06	0.000158	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.88e-06	0.000157	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.85e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.38e-06	0.000137	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—INS—Alzheimer's disease	3.32e-06	0.000134	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.91e-06	0.000118	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	2.88e-06	0.000117	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.66e-06	0.000108	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKT1—Alzheimer's disease	2.49e-06	0.000101	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	2.03e-06	8.21e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.34e-06	5.41e-05	CbGpPWpGaD
